Search

everythinglearnresearchcommunity

for

Search:↓

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Pranlukast and mirabegron may work as new diabetes drugs.

GPR40 agonists help hair growth through the protein ANGPTL4.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

GnRH treatment can reduce breast cancer cell invasion.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

The compounds tested could potentially treat hair loss and alopecia.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Potential new drugs for treating PCOS were identified.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

0.5% TPGS boosts hair growth with minoxidil, but 2% TPGS increases minoxidil absorption.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

DMSO causes reversible swelling in hair but has a complex, less reversible effect on skin.

Human liver enzyme DHEA ST helps process minoxidil.

Salvianolic acid B promotes hair growth better than minoxidil.